Skip to main navigation Skip to search Skip to main content

FDA Review of FT218 in Narcolepsy Pushed Back to 2023

Press/Media: Press / Media

PeriodMay 31 2022

Media coverage

1

Media coverage

  • TitleFDA Review of FT218 in Narcolepsy Pushed Back to 2023
    Media name/outletNeurology Live
    Country/TerritoryUnited States
    Date5/31/22
    PersonsAsim Roy